Erratum: A quantitative approach to benefit‐risk assessment of medicines — part 2: the practical application of a new model
Open Access
- 5 July 2007
- journal article
- correction
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 16 (8) , 946
- https://doi.org/10.1002/pds.1460
Abstract
Pharmacoepidemiology and Drug Safety 2007; 16: S16—S41; DOI: 10.1002/pds.1434It has come to the attention of the authors that this published article contained an error.The author Lawrence Phillips was mistakenly omitted from the original article. The full list of authors and affiliations can be seen below.Filip Mussen1,2, Sam Salek2, Stuart Walker3 and Lawrence Phillips41Regulatory Affairs Europe, Merck Sharp & Dohme (Europe), Inc., 5 Lynx Binnenhof, Brussels, B‐1200, Belgium2Centre for Socioeconomic Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff CF10 3XF, UK3CMR International, Novellus Court, 61 South Street, Epsom, Surrey, KT18 7PX, UK4Visiting Professor of Decision Sciences, Department of Management, Operational Research Group, London School of Economics, UKThe authors wish to apologise for any inconvenience caused.Keywords
This publication has 0 references indexed in Scilit: